%0 Journal Article
%T Implementation of the CALM intervention for anxiety disorders: a qualitative study
%A Geoffrey M Curran
%A Greer Sullivan
%A Peter Mendel
%A Michelle G Craske
%A Cathy D Sherbourne
%A Murray B Stein
%A Ashley McDaniel
%A Peter Roy-Byrne
%J Implementation Science
%D 2012
%I BioMed Central
%R 10.1186/1748-5908-7-14
%X Key informant interviews were conducted with 47 clinic staff members (18 primary care providers, 13 nurses, 8 clinic administrators, and 8 clinic staff) and 14 study-trained anxiety clinical specialists (ACSs) who coordinated the collaborative care and provided cognitive behavioral therapy. The interviews were semistructured and conducted by phone. Data were content analyzed with line-by-line analyses leading to the development and refinement of themes.Similar themes emerged across stakeholders. Important facilitators to implementation included the perception of "low burden" to implement, provider satisfaction with the intervention, and frequent provider interaction with ACSs. Barriers to implementation included variable provider interest in mental health, high rates of part-time providers in clinics, and high social stressors of lower socioeconomic-status patients interfering with adherence. Key sustainability facilitators were if a clinic had already incorporated collaborative care for another disorder and presence of onsite mental health staff. The main barrier to sustainability was funding for the ACS.The CALM intervention was relatively easy to incorporate during the effectiveness trial, and satisfaction was generally high. Numerous implementation and sustainability barriers could limit the reach and impact of widespread adoption. Findings should be interpreted with the knowledge that the ACSs in this study were provided and trained by the study. Future research should explore uptake of CALM and similar interventions without the aid of an effectiveness trial.Anxiety disorders are highly prevalent. In the United States, population surveys estimate that close to 29% have experienced an anxiety disorder in their lifetime [1], while about 18% experience an anxiety disorder each year [2]. Individuals with anxiety disorders suffer significant impairment and reduced quality of life [3-5], and they are costly to healthcare systems and economies in general due to high u
%U http://www.implementationscience.com/content/7/1/14